LUIS GONZAGA
PAZ-ARES RODRÍGUEZ
Profesor titular de universidad
Austin Hospital
Melbourne, AustraliaAustin Hospital-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2021
-
First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial
The Lancet Oncology, Vol. 22, Núm. 2, pp. 198-211